Broadway Star Valisia LeKae Debuts Ovarian Cancer PSA in Times Square
“God has given me another role to play and like all my previous roles, I plan to go all in, only this time I plan to Win!” — Broadway star Valisia LeKae Broadway star Valisia LeKae is a 2013 Tony Award nominee for “Best Actress in a Musical” for her performance as Diana Ross in […] (Source: Libby's H*O*P*E*)
Source: Libby's H*O*P*E* - May 1, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Advocacy Inspirational David Fishman M.D. Elizabeth Remick Motown The Musical Mt. Sinai Ovarian Cancer Risk Assessment Program ovarian clear cell carcinoma Peter Hapak salpingo-oophorectomy Times Square Toshiba Toshiba Vision Screens Source Type: blogs
Shannon’s Story: Confronting Ovarian Cancer
My name is Shannon. I am from Charlotte, NC. I am married.
In July of 2009, I had just returned from my dream vacation to France. Not even a month later, following a few trips to the gynecologist with complaints of abdominal pain, I was sitting in the office of a gynecologic oncologist. I had never even heard those words used in a sentence. I was being prepped for surgery to remove a cyst.
One week later, I was diagnosed with Stage IIa clear cell carcinoma, a form of ovarian cancer considered rare in younger women. Within two weeks of being diagnosed, I had a radical hysterectomy and a few weeks ...
Source: Disruptive Women in Health Care - September 12, 2013 Category: Health Medicine and Bioethics Commentators Authors: dw at disruptivewomen.net Tags: Cancer Caregiving Women's Health Source Type: blogs
ENMD-2076 Monotherapy Demonstrates Anti-Cancer Activity in Recurrent, Platinum-Resistant Ovarian Clear Cell Carcinoma
An Aurora A/angiogenic kinase inhibitor named “ENMD-2076″ demonstrated anti-cancer activity in recurrent, platinum-resistant epithelial ovarian cancer patients, including three patients with a difficult-to-treat subtype of the disease referred to as “clear cell carcinoma.” An Aurora A/angiogenic kinase inhibitor named “ENMD-2076” demonstrated anti-cancer activity in recurrent, platinum-resistant epithelial ovarian cancer patients, including three patients with a [...] (Source: Libby's H*O*P*E*)
Source: Libby's H*O*P*E* - January 14, 2013 Category: Cancer Authors: Paul Cacciatore Tags: Clinical Trial Results Novel Therapies Pipeline Drugs Targeted Therapies angiogenic kinase inhibitor Aurora A kinase inhibitor Campbell Family Institute for Cancer Research clear cell carcinoma Dana-Farber Cancer Institute ENMD-2076 En Source Type: blogs
---
ImmunohistochemistryImmunohistochemistry in the differential diagnosis ofclear cell carcinomas from the kidney, liver, and lung Clear cell carcinoma is a common specimen seen by many surgical pathologists. Given an appropriate clinical context (for example, a patient with a large kidney mass), determining the nature and origin of a clear cell carcinoma can be very easy. However, in other situations this can be a challenging task, primarily because of the tremendous degree of overlap in the morphologic appearance of clear cell carcinomas from different primary sites. This month, we discuss the utility of a number ...
Source: Oncopathology - April 2, 2012 Category: Cancer & Oncology Source Type: blogs
